Post-remission cytopenia management in patients with AML treated with venetoclax in combination with hypomethylating agents: Pre- versus post-VIALE-A real-world experience from a predominantly US community setting
Vachhani, Pankit, Ma, Esprit, Xu, Tao, Montez, Melissa, Worth, Sarah, Yellow-Duke, Archibong, Cheng, Wei-Han, Werner, Michael E, Abbas, Jonathan, Donnellan, William
Published in Cancer medicine (Malden, MA) (01.09.2023)
Published in Cancer medicine (Malden, MA) (01.09.2023)
Get full text
Journal Article
Treatment Outcomes of Stem Cell Transplant in Patients with Acute Myeloid Leukemia Treated with Venetoclax in Combination with Hypomethylating Agents: Experience from Routine Clinical Practices in the United States
Bachiashvili, Kimo, Ma, Esprit, Patel, Achal, Wang, Rongrong, Yellow-Duke, Archibong, Montez, Melissa, Bui, Cat N., Worth, Sarah, Vachhani, Pankit
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Real-World Treatment Experience of Venetoclax in Combination with Hypomethylating Agents in Patients with Newly Diagnosed Acute Myeloid Leukemia: Updated Experience from a Predominately Community Setting in the US
Vachhani, Pankit, Ma, Esprit, Xu, Tao, Montez, Melissa, Worth, Sarah, Cheng, Wei-Han, Werner, Michael, Abbas, Jonathan, Donnellan, William
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
The Cytogenetic and Molecular Testing Landscape in Patients with Newly Diagnosed Acute Myeloid Leukemia in Routine Clinical Practices in the United States
Bachiashvili, Kimo, Harada, Shuko, Ma, Esprit, Patel, Achal, Wang, Rongrong, Yellow-Duke, Archibong, Montez, Melissa, Chopra, Vivek, Bui, Cat N., Vachhani, Pankit
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Unmet Medical Needs Amongst Older Patients Aged ≥60 Years with Newly Diagnosed Acute Myeloid Leukemia Receiving Intensive Chemotherapy: Experience from a Predominately United States Community Setting
Kadia, Tapan M., Bataller, Alex, Ma, Esprit, Patel, Achal, Wang, Rongrong, Yellow-Duke, Archibong, Montez, Melissa, Bui, Cat N., Ravandi, Farhad
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Venetoclax and Hypomethylating Agents as First-line Treatment in Newly Diagnosed Patients with AML in a Predominately Community Setting in the US
Vachhani, Pankit, Flahavan, Evelyn M, Xu, Tao, Ma, Esprit, Montez, Melissa, Gershon, Anda, Onishi, Maika, Jin, Huan, Ku, Grace, Flores, Brannon, Bui, Cat N, Abbas, Jonathan A, Donnellan, William
Published in The oncologist (Dayton, Ohio) (03.11.2022)
Published in The oncologist (Dayton, Ohio) (03.11.2022)
Get full text
Journal Article
Cost Effectiveness Analysis of Venetoclax Plus Azacitidine Versus Azacitidine in Newly Diagnosed Adult Patients with Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy from a United States Payer Perspective
Pratz, Keith W., Chai, Xinglei, Xie, Jipan, Yin, Lei, Nie, Xiaoyu, Montez, Melissa, Iantuono, Erica, Downs, Lisa, Ma, Esprit
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Real-World Treatment Patterns and Transfusion Burden Among Newly Diagnosed Older Adults with Acute Myeloid Leukemia
Zeidan, Amer M., Cheng, Wei-Han, Kamalakar, Rajesh, Miller, Catherine, Bui, Cat N., Montez, Melissa, Yee, Tracy, Wu, Zheng, Huntington, Scott F.
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Cost-Effectiveness Analysis of Venetoclax in Combination with Azacitidine Versus Azacitidine Monotherapy in Patients with Acute Myeloid Leukemia Who are Ineligible for Intensive Chemotherapy: From a US Third Party Payer Perspective
Pratz, Keith W., Chai, Xinglei, Xie, Jipan, Yin, Lei, Nie, Xiaoyu, Montez, Melissa, Iantuono, Erica, Downs, Lisa, Ma, Esprit
Published in PharmacoEconomics (01.08.2022)
Published in PharmacoEconomics (01.08.2022)
Get full text
Journal Article
Healthcare resource utilization and total cost of care in older patients with acute myeloid leukemia ineligible for intensive chemotherapy
LeBlanc, Thomas William, Seetasith, Arpamas, Choi, Michelle E, Surinach, Andy, To, Tu My, Montez, Melissa, Ma, Esprit
Published in Journal of clinical oncology (10.10.2020)
Published in Journal of clinical oncology (10.10.2020)
Get full text
Journal Article
Application of a Validated Composite Comorbidity Score Measuring Both Fitness and Cytogenetic Risk to Assess Outcomes in 1L AML Patients Who Received Venetoclax Plus Azacitidine in Viale-A
Venditti, Adriano, Hou, Jing-Zhou, Fenaux, Pierre, Jonas, Brian A., Vrhovac, Radovan, Montesinos, Pau, Garcia, Jacqueline S., Rizzieri, David, Thirman, Michael J., Montez, Melissa, Liu, Yingyi, Katsetos, John, Potluri, Jalaja, Miller, Catherine, Pullarkat, Vinod A.
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Treatment Patterns and Outcomes of Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Treated with Hypomethylating Agents (HMA) in the United States (US)
Pardee, Timothy S., Oschwald, Jessica, Ma, Esprit, Xu, Tao, Montez, Melissa, Ramsingh, Giridharan, Hong, Wan-Jen, Choi, Michelle, Flahavan, Evelyn M.
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Use of Venetoclax (VEN) and Hypomethylating Agents (HMA) in Newly Diagnosed Acute Myeloid Leukemia (AML) in the United States (US) - Real World (RW) Response, Treatment Duration, Dose and Schedule Modifications
Donnellan, William, Xu, Tao, Ma, Esprit, Jin, Huan, Montez, Melissa, Choi, Michelle, Ku, Grace, Rajeswaran, Raj Anand, Ramsingh, Giridharan, Flahavan, Evelyn M.
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Real World Treatment Patterns and Outcomes of Venetoclax (Ven) and Hypomethylating Agents (HMA) in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) in the United States
Vachhani, Pankit, Abbas, Jonathan A., Flahavan, Evelyn M., Ma, Esprit, Xu, Tao, Jin, Huan, Montez, Melissa, Huang, Weize, Gershon, Anda, Ku, Grace, Flores, Brannon, Onishi, Maika, Bui, Cat N., Donnellan, William
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Postremission cytopenia management in patients with acute myeloid leukemia treated with venetoclax and azacitidine in VIALE‐A
Pratz, Keith W., DiNardo, Courtney D., Selleslag, Dominik, Li, Junmin, Yamamoto, Kazuhito, Konopleva, Marina, Stevens, Don, Kantarjian, Hagop, Traina, Fabiola, Venditti, Adriano, Mayer, Jiri, Montez, Melissa, Jin, Huan, Duan, Yinghui, Brackman, Deanna, Zha, Jiuhong, Potluri, Jalaja, Werner, Michael, Jonas, Brian A.
Published in American journal of hematology (01.11.2022)
Published in American journal of hematology (01.11.2022)
Get full text
Journal Article
Comparison of Patients with Newly Diagnosed (ND) Acute Myeloid Leukemia (AML) Treated with Venetoclax and Hypomethylating Agents Vs Other Therapies By TP53 and IDH1/2 Mutation: Results from the AML Real World Evidence (ARC) Initiative
Wolach, Ofir, Garcia, Jacqueline S., Desai, Pinkal, Vachhani, Pankit, Zeidner, Joshua F., Abedin, Sameem, Sweet, Kendra, Lai, Catherine, Moshe, Yakir, Pollyea, Daniel A., Xavier, Marin, Nachmias, Boaz, Zuckerman, Tsila, Lee, Sangmin, Chen, Evan C., Bathini, Srilakshmi, Edwards, Wesleigh, Bui, Cat N., Cheng, Wei-Han, Miller, Catherine, Guerin, Annie, Maitland, Jessica, Ma, Esprit, Montez, Melissa, Grunspan, Moshe, Goldberg, Aaron D
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Early Real-World First-Line Treatment With Venetoclax Plus HMAs Versus HMA Monotherapy Among Patients With AML in a Predominately US Community Setting
Gershon, Anda, Ma, Esprit, Xu, Tao, Montez, Melissa, Naqvi, Kiran, Ku, Grace, Cheng, Wendy Wei-Han, Flahavan, Evelyn M., Kota, Vamsi, Greenwald, Daniel R.
Published in Clinical lymphoma, myeloma and leukemia (01.05.2023)
Published in Clinical lymphoma, myeloma and leukemia (01.05.2023)
Get full text
Journal Article
What are the health care costs for chronic lymphocytic leukemia?
Matasar, Matthew J., DaCosta Byfield, Stacey, Blauer-Peterson, Cori, Montez, Melissa, Reyes, Carolina, Masaquel, Anthony
Published in Journal of clinical oncology (10.03.2017)
Published in Journal of clinical oncology (10.03.2017)
Get full text
Journal Article
Real-World Health Care Utilization and Costs Among Patients Newly Initiating Systemic Therapy for Chronic Lymphocytic Leukemia (CLL) in the United States
Matasar, Matthew J., Dacosta Byfield, Stacey, Blauer-Peterson, Cori, Montez, Melissa, Reyes, Carolina, Masaquel, Anthony
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article
Real-World Management of Patients with Newly Diagnosed Acute Myeloid Leukemia Treated with Venetoclax-Based Regimens: Results from the AML Real World Evidence (ARC) Initiative
Vachhani, Pankit, Wolach, Ofir, Garcia, Jacqueline S., Zeidner, Joshua F., Talati, Chetasi, Pollyea, Daniel A., Lai, Catherine, Moshe, Yakir, Abedin, Sameem, Lavie, David, Zuckerman, Tsila, Xavier, Marin, Lee, Sangmin, Chen, Evan, Edwards, Wesleigh, Bui, Cat N., Svensson, Anders, Kye, Steve, Burne, Rebecca, Maitland, Jessica, Ma, Esprit, Montez, Melissa, Grunspan, Moshe, Goldberg, Aaron D
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article